Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Mediterranean diet improves cardiovascular health of middle-aged women

Mediterranean diet

Following the popular Mediterranean diet instead of a “Western” diet can be quite beneficial for women in their forties and fifties, researchers confirmed. 

  • Read more about Mediterranean diet improves cardiovascular health of middle-aged women

Bayer ends blood thinner trial early due to lack of efficacy

Stop

The Independent Data Monitoring Committee recommended Bayer stop the trial due to the drug's poor performance compared to apixaban. 

  • Read more about Bayer ends blood thinner trial early due to lack of efficacy

ADHD medications associated with heightened CVD risk

Pills

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

  • Read more about ADHD medications associated with heightened CVD risk

Sensitivity to dairy products, other foods linked to higher risk of death from heart disease

milk dairy products

Even patients with no symptoms may be at risk, according to new findings published in the Journal of Allergy and Clinical Immunology.

  • Read more about Sensitivity to dairy products, other foods linked to higher risk of death from heart disease

Medtronic gains 2 key approvals for its ablation portfolio

Medtronic's PulseSelect Pulsed Field Ablation (PFA) System

Medtronic's PulseSelect Pulsed Field Ablation System. Image courtesy of Medtronic.

The company had good news to share about its highly anticipated PFA offering.

  • Read more about Medtronic gains 2 key approvals for its ablation portfolio

Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists

artificial intelligence consultation

More and more AI algorithms are being trained to learn, think and act like a human physician. What does this mean for the future of cardiovascular imaging as time goes on?

  • Read more about Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists

Smartphone app helps TAVR patients avoid major complications

Smartphone

Hospital readmissions, ER visits and major complications were all less likely when TAVR patients used a smartphone app to assist with their recovery. 

  • Read more about Smartphone app helps TAVR patients avoid major complications

FDA clears AI-powered image reconstruction technology for cardiac CT scanners

Arineta Cardio Imaging, a healthcare company based in Israel, gained clearance from the U.S. Food and Drug Administration (FDA) for the deep learning image reconstruction (DLIR) technology used in its SpotLight cardiovascular CT scanners. Arineta Cardio Imaging cardiovascular CT scanners AI.

Image courtesy of Arineta Cardio Imaging. 

The new technology, trained using more than 3 billion data points, was designed to reduce image noise and improve the overall quality of CT scans. 

  • Read more about FDA clears AI-powered image reconstruction technology for cardiac CT scanners

FDA approves another renal denervation system for hypertension

Medtronic Symplicity Spyral renal denervation

Symplicity Spyral image courtesy of Medtronic.

This is the second time in a matter of weeks the FDA has approved an RDN system for uncontrolled hypertension. The SCAI issued a statement about this trend, calling it a “game-changer for both interventional cardiology and the treatment of hypertension."

  • Read more about FDA approves another renal denervation system for hypertension

Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades

A new gene-editing therapy has been tested on humans for the first time, resulting in a significant reduction in their low-density lipoprotein (LDL) cholesterol that could potentially last for decades. The study’s authors presented these early results at the AHA 2023 meeting.

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

  • Read more about Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …262
    • Page 263
    • Page 264
    • Page 265
    • Current page 266
    • Page 267
    • Page 268
    • Page 269
    • Page 270 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme